Retatrutide peptide API

Product Name: Retatrutide Peptide API

CAS No.: 2381089-83-2
Molecular Formula: C221H342N46O68
Molecular Weight: ~4732.09
Purity: ≥99% by HPLC
Appearance: White  powder
Grade: Pharmaceutical Grade
Shelf Life: 24 months
Storage: 2-8°C, protected from light, sealed storage
US DMF Status: In preparation (contact for update)
GMP Compliance: Manufactured under cGMP standards

Overview
Retatrutide (LY3437943) is a synthetic peptide API developed by Eli Lilly, currently the most advanced triple agonist in global clinical development (Phase 3 TRIUMPH program). It uniquely combines glucagon, GIP, and GLP-1 receptor activation, offering a next-generation approach for obesity, type 2 diabetes, and metabolic diseases.

Our Retatrutide API is produced under strict cGMP standards, with ≥99% purity and a 24-month shelf life under recommended storage conditions (2-8°C, protected from light). The US DMF is currently in preparation, supporting your regulatory filings.

Key Specifications

Why Choose Our Retatrutide API？
High purity – ≥99% by HPLC, consistent batch-to-batch quality

cGMP manufacturing – suitable for pharmaceutical R&D and clinical supply

Regulatory support – US DMF in preparation to assist your IND/NDA filings

Stable supply chain – reliable production capacity for research to commercial scales

Proven stability – 24-month shelf life at 2-8°C

Applications
Preclinical and clinical research for obesity and type 2 diabetes mellitus

Formulation development of once-weekly injectable peptides

Reference standard for analytical method development

API supply for clinical trial materials

Documentation Available
Certificate of Analysis (COA)

Stability data

GMP statement

DMF (in preparation – contact for status)

Packaging & Shipping
Standard packaging: sealed pharmaceutical-grade containers

Temperature-controlled shipping (2-8°C) for global delivery

Custom packaging available upon request

Contact Us
For pricing, DMF status updates, or sample requests, please contact our sales team.